AG

Artal Group Portfolio holdings

AUM $930M
This Quarter Return
-23.2%
1 Year Return
-3.57%
3 Year Return
+157.23%
5 Year Return
+160.22%
10 Year Return
+1,359.85%
AUM
$2.01B
AUM Growth
+$2.01B
Cap. Flow
+$140M
Cap. Flow %
6.96%
Top 10 Hldgs %
70.26%
Holding
110
New
9
Increased
21
Reduced
12
Closed
14

Top Buys

1
MRNA icon
Moderna
MRNA
$80.3M
2
BABA icon
Alibaba
BABA
$47.6M
3
NIO icon
NIO
NIO
$26.1M
4
ALLO icon
Allogene Therapeutics
ALLO
$10.8M
5
ARRY
Array Biopharma Inc
ARRY
$8.55M

Top Sells

1
TSRO
TESARO, Inc.
TSRO
$31.2M
2
FOLD icon
Amicus Therapeutics
FOLD
$9.58M
3
ANAB icon
AnaptysBio
ANAB
$9.57M
4
ZGNX
Zogenix, Inc.
ZGNX
$7.29M
5
ALNY icon
Alnylam Pharmaceuticals
ALNY
$7.29M

Sector Composition

1 Healthcare 65.65%
2 Consumer Discretionary 33.07%
3 Real Estate 0.37%
4 Communication Services 0.16%
5 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
DNTH icon
76
Dianthus Therapeutics
DNTH
$759M
$1.14M 0.04% 200,000 – –
YMAB icon
77
Y-mAbs Therapeutics
YMAB
$388M
$1.02M 0.04% 50,000 -100,000 -67% -$2.03M
TRIL
78
DELISTED
Trillium Therapeutics Inc.
TRIL
$257K 0.01% 150,000 – –
NVLN
79
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
$215K 0.01% 256,400 – –
AAL icon
80
American Airlines Group
AAL
$8.82B
– – 0 – –
ADVM icon
81
Adverum Biotechnologies
ADVM
$64.6M
– – -400,000 Closed -$2.42M
BAC icon
82
Bank of America
BAC
$376B
– – 0 – –
BMRN icon
83
BioMarin Pharmaceuticals
BMRN
$11.2B
– – 0 – –
BMY icon
84
Bristol-Myers Squibb
BMY
$96B
– – 0 – –
C icon
85
Citigroup
C
$178B
– – 0 – –
ELAN icon
86
Elanco Animal Health
ELAN
$9.12B
– – -100,000 Closed -$3.49M
FCX icon
87
Freeport-McMoran
FCX
$63.7B
– – 0 – –
FLEX icon
88
Flex
FLEX
$20.1B
– – -250,000 Closed -$3.28M
GM icon
89
General Motors
GM
$55.8B
– – 0 – –
GS icon
90
Goldman Sachs
GS
$226B
– – 0 – –
MLCO icon
91
Melco Resorts & Entertainment
MLCO
$3.88B
– – 0 – –
MS icon
92
Morgan Stanley
MS
$240B
– – 0 – –
MU icon
93
Micron Technology
MU
$133B
– – 0 – –
NTLA icon
94
Intellia Therapeutics
NTLA
$1.22B
– – -90,000 Closed -$2.58M
NVAX icon
95
Novavax
NVAX
$1.21B
– – -500,000 Closed -$940K
IMDX
96
Insight Molecular Diagnostics Inc. Common Stock
IMDX
$72.4M
– – -150,000 Closed -$375K
SYBX icon
97
Synlogic
SYBX
$17M
– – -200,000 Closed -$2.84M
UBX
98
DELISTED
Unity Biotechnology
UBX
– – -50,000 Closed -$815K
VALE icon
99
Vale
VALE
$43.9B
– – 0 – –
WFC icon
100
Wells Fargo
WFC
$263B
– – 0 – –
1 2 3
4
5